Literature DB >> 26135594

Fidaxomicin Pharmacokinetics in Humans: Is There a Role of Biliary Excretion?

Nuggehally R Srinivas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26135594     DOI： 10.1007/s40261-015-0305-7

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  3 in total

1.  Killing kinetics of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile.

Authors:  Farah Babakhani; Abraham Gomez; Nikki Robert; Pamela Sears
Journal:  J Med Microbiol       Date:  2011-02-24       Impact factor: 2.472

Review 2.  Fidaxomicin: a novel macrolide antibiotic for Clostridium difficile infection.

Authors:  Elias B Chahine; Allana J Sucher; Karelee Mantei
Journal:  Consult Pharm       Date:  2014-09

3.  Comparison of the safety, tolerability, and pharmacokinetics of fidaxomicin in healthy Japanese and caucasian subjects.

Authors:  Hiroyuki Oshima; Takao Yamazaki; Lauren Benner; Takashi Miki; Ingrid Michon; Tomasz Wojtkowski; Atsunori Kaibara; Salim Mujais
Journal:  Clin Drug Investig       Date:  2015-06       Impact factor: 2.859
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.